✨ Classification of Medicines




NEW ZEALAND GAZETTE, No. 12 β€” 11 FEBRUARY 2016

Classification of Medicines

Pursuant to section 106(1) of the Medicines Act 1981, I, Dr Stewart Jessamine, Acting Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health, acting under delegated authority, hereby declare the following:

  1. The medicines listed in Schedule 1 to this notice are classified as prescription medicines.
  2. The medicines listed in Schedule 2 to this notice are classified as restricted medicines.
  3. The medicines listed in Schedule 3 to this notice are classified as pharmacy-only medicines.

Every reference to a medicine in this notice applies whether the medicine is synthetic in origin or is from biological or mineral sources.

Unless specific reference is made otherwise, every reference applies also to medicines that are:

a. preparations and admixtures containing any proportion of any substance listed in the notice.

b. salts and esters of any substance listed in the notice.

c. preparations or extracts of biological materials listed in the notice.

d. salts or oxides of elements listed in the notice.

Unless specific reference is made otherwise, every reference to a medicine applies:

i. if the medicine is in an injection or eye preparation, to any concentration of that medicine; and

ii. if the medicine is not in an injection or eye preparation, only if the concentration of the medicine is greater than 10 milligrams per litre or per kilogram.

Where any reference is modified by a statement of the strength of the medicine, the strength is calculated using the free acid, base, alcohol or element unless specifically stated otherwise.

Schedule 1

Prescription Medicines

Aloracetam
Aniracetam
Apremilast
Azelastine; except when specified elsewhere in this notice
Bedaquiline
Bilastine; except when specified elsewhere in this notice
Bosutinib
Brentuximab vedotin
Brivaracetam (and its stereoisomers)
Carglumic acid
Cebaracetam (and its stereoisomers)
Coluracetam
Dimiracetam (and its stereoisomers)
Doliracetam (and its stereoisomers)
Dupracetam
Etiracetam
Elosulfase alfa
Fasoracetam (and its stereoisomers)
Fomepizole
Fonturacetam (and its stereoisomers)
Idarucizumab
Idelalisib



Next Page →



Online Sources for this page:

Gazette.govt.nz PDF NZ Gazette 2016, No 12





✨ LLM interpretation of page content

πŸ₯ Classification of Medicines under the Medicines Act 1981

πŸ₯ Health & Social Welfare
Medicines, Classification, Prescription Medicines, Restricted Medicines, Pharmacy-only Medicines
  • Dr Stewart Jessamine, Acting Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health